Akso Health Group Sponsored ADR (8HX) Stock Statistics & Valuation Metrics
Total Valuation
Akso Health Group Sponsored ADR has a market cap or net worth of EUR 966.53M. The enterprise value is EUR 105.45T.
- Market Cap
- EUR 966.53M
- Enterprise Value
- EUR 105.45T
Share Statistics
Akso Health Group Sponsored ADR has 854,043,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 854,043,900
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Akso Health Group Sponsored ADR’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -1.99%.
- Return on Equity (ROE)
- -0.10
- Return on Assets (ROA)
- -0.10
- Return on Invested Capital (ROIC)
- -1.99%
- Return on Capital Employed (ROCE)
- -0.02
- Revenue Per Employee
- 1.15M
- Profits Per Employee
- -1.56M
- Employee Count
- 12
- Asset Turnover
- 0.07
- Inventory Turnover
- 69.17
Valuation Ratios
The current PE Ratio of Akso Health Group Sponsored ADR is -19.53. Akso Health Group Sponsored ADR’s PEG ratio is -0.13.
- PE Ratio
- -19.53
- PS Ratio
- 81.04
- PB Ratio
- 5.24
- Price to FCF
- -10.53
- Price to Operating Cash Flow
- -51.08
- PEG Ratio
- -0.13
Income Statement
In the last 12 months, Akso Health Group Sponsored ADR had revenue of 13.83M and earned -18.67M in profits. Earnings per share was -0.03.
- Revenue
- 13.83M
- Gross Profit
- -11.31K
- Operating Income
- -4.00M
- Pretax Income
- -20.70M
- Net Income
- -18.67M
- EBITDA
- -1.63M
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -18.57M and capital expenditures -87.84M, giving a free cash flow of -106.41M billion.
- Operating Cash Flow
- -18.57M
- Free Cash Flow
- -106.41M
- Free Cash Flow per Share
- -0.15
Dividends & Yields
Akso Health Group Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.09%
- Earnings Yield
- -2.89%
Stock Price Statistics
- Beta
- 0.31
- 52-Week Price Change
- -16.54%
- 50-Day Moving Average
- 0.82
- 200-Day Moving Average
- 1.25
- Relative Strength Index (RSI)
- 57.52
- Average Volume (3m)
- ―
Financial Position
Akso Health Group Sponsored ADR as a current ratio of 21.77, with Debt / Equity ratio of 0.21%
- Current Ratio
- 21.77
- Quick Ratio
- 21.74
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.13
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Akso Health Group Sponsored ADR has paid -1.99M in taxes.
- Income Tax
- -1.99M
- Effective Tax Rate
- 0.10
Enterprise Valuation
Akso Health Group Sponsored ADR EV to EBITDA ratio is -718.63, with an EV/FCF ratio of -11.00.
- EV to Sales
- 84.60
- EV to EBITDA
- -718.63
- EV to Free Cash Flow
- -11.00
- EV to Operating Cash Flow
- -63.02
Balance Sheet
Akso Health Group Sponsored ADR has EUR 170.57K in cash and marketable securities with EUR 375.66K in debt, giving a net cash position of -EUR 205.09K billion.
- Cash & Marketable Securities
- EUR 170.57K
- Total Debt
- EUR 375.66K
- Net Cash
- -EUR 205.09K
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.25
Margins
Gross margin is -0.08%, with operating margin of -28.92%, and net profit margin of -207.10%.
- Gross Margin
- -0.08%
- Operating Margin
- -28.92%
- Pretax Margin
- -149.69%
- Net Profit Margin
- -207.10%
- EBITDA Margin
- -11.77%
- EBIT Margin
- -28.92%
Analyst Forecast
The average price target for Akso Health Group Sponsored ADR is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -13.36%
- EPS Growth Forecast
- 95.68%
Scores
- Smart Score
- 3
- AI Score
- ―
